US Pharma MarketingInterruptions in the supply of neurosurgical patties, sponges and strips are expected to continue through 2026.
FDA warns of neurosurgical supply disruptions
FDA warns of neurosurgical supply disruptions is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: MedTech Dive